CD59 and cancer: To evaluate the effects of TAMs on CD59 expression in cancer cells, we examined the expression levels of CD59 protein in 7 human pancreatic cancer cell lines (BxPC-3, MiaPaCa-2, T3M4, PANC-1, AsPC-1, Su86.86, and CFPAC-1, Fig. 3a) and selected AsPC-1 as the high expression group.